Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3696)
All Articles published online
|
Oct 7, 2010 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Xue XB, Xiao CW, Zhang H, Lu AG, Gao W, Zhou ZQ, Guo XL, Zhong MA, Yang Y, Wang CJ. Oncolytic adenovirus SG600-IL24 selectively kills hepatocellular carcinoma cell lines. World J Gastroenterol 2010; 16(37): 4677-4684 [PMID: 20872968 DOI: 10.3748/wjg.v16.i37.4677] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i37/4677.htm |
| Number | Citing Articles |
| 1 |
Chao Ma, Ling‑Ling Zhao, Heng‑Jun Zhao, Jiu‑Wei Cui, Wei Li, Nan‑Ya Wang. Lentivirus‑mediated MDA7/IL24 expression inhibits the proliferation of hepatocellular carcinoma cells. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8616
|
| 2 |
Arseniy E. Yuzhalin, Anton G. Kutikhin. Interleukins in Cancer Biology. 2015; : 147 doi: 10.1016/B978-0-12-801121-8.00006-3
|
| 3 |
Cong-Jun Wang, Chao-Wen Xiao, Tian-Geng You, Ya-Xin Zheng, Wei Gao, Zhu-Qing Zhou, Jun Chen, Xin-Bo Xue, Jia Fan, Hui Zhang. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma. Molecular Cancer 2012; 11(1) doi: 10.1186/1476-4598-11-31
|
| 4 |
Hua Tian, Chao Ge, Hong Li, Fangyu Zhao, Helei Hou, Taoyang Chen, Guoping Jiang, Haiyang Xie, Ying Cui, Ming Yao, Jinjun Li. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma. Hepatology 2014; 59(4): 1459 doi: 10.1002/hep.26929
|
| 5 |
Erin L. Whitaker, Valery A. Filippov, Penelope J. Duerksen-Hughes. Interleukin 24: Mechanisms and therapeutic potential of an anti-cancer gene. Cytokine & Growth Factor Reviews 2012; 23(6): 323 doi: 10.1016/j.cytogfr.2012.08.004
|
| 6 |
Ding Wei, Jing Xu, Xin-Yuan Liu, Zhi-Nan Chen, Huijie Bian. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China. Human Gene Therapy 2018; 29(2): 151 doi: 10.1089/hum.2017.212
|
| 7 |
Mubalake Abudoureyimu, Yongting Lai, Chuan Tian, Ting Wang, Rui Wang, Xiaoyuan Chu. Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01182
|
| 8 |
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn. Transcriptional regulators in hepatocarcinogenesis – Key integrators of malignant transformation. Journal of Hepatology 2012; 57(1): 186 doi: 10.1016/j.jhep.2011.11.029
|
| 9 |
Swadesh K. Das, Siddik Sarkar, Rupesh Dash, Paul Dent, Xiang-Yang Wang, Devanand Sarkar, Paul B. Fisher. Applications of viruses for cancer therapy. Advances in Cancer Research 2012; 115: 1 doi: 10.1016/B978-0-12-398342-8.00001-X
|